Projects per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
OPERA: Netherlands study of Optimal, Personal Antidepressant use
Penninx, B., Bot, M., Maarsingh, O., Vinkers, C. & Bet, P.
1/01/2019 → 31/12/2023
Project: Research
-
A new approach to drug intravenous compatibility research: The case of obstetric parenteral drugs
Leeuwerik, A. F., van Merendonk, L. N., de Boer, M. A., Wilhelm, A. J., Kolkman, A. & Bet, P. M., 2023, (E-pub ahead of print) In: European Journal of Hospital Pharmacy. ejhpharm-2022-003577.Research output: Contribution to journal › Article › Academic › peer-review
-
Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
Zwiep, J. C., Bet, P. M., Rhebergen, D., Nurmohamed, M. T., Vinkers, C. H., Penninx, B. W. J. H., Milaneschi, Y. & Lamers, F., Feb 2023, In: Brain, behavior, & immunity - health. 27, p. 100585 100585.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Methylphenidate dose-response in children with ADHD: evidence from a double-blind, randomized placebo-controlled titration trial
Vertessen, K., Luman, M., Swanson, J. M., Bottelier, M., Stoffelsen, R., Bet, P., Wisse, A., Twisk, J. W. R. & Oosterlaan, J., 2 Mar 2023, (E-pub ahead of print) In: European child & adolescent psychiatry.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19
Baalbaki, N., Duijvelaar, E., Said, M. M., Schippers, J., Bet, P. M., Twisk, J., Fritchley, S., Longo, C., Mahmoud, K., Maitland-van der Zee, A. H., Bogaard, H. J., Swart, E. L., Aman, J. & Bartelink, I. H., 1 May 2023, In: European journal of pharmaceutical sciences. 184, 106418.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial: Three -years follow- up of a placebo-controlled trial
Rusman, T., van der Weijden, M. A. C., Nurmohamed, M. T., van Denderen, C. J., Landewé, R. B. M., Bet, P. M., Bijl, C. MA., van der Laken, C. J., van der Horst-Bruinsma, I. E. & Bijl, C. V. D., 11 May 2022, (E-pub ahead of print) In: Scandinavian Journal of Rheumatology. p. 1-5 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access